Dabigatran With or Without Concomitant Aspirin Compared With Warfarin Alone in Patients With Nonvalvular Atrial Fibrillation (PETRO Study)
Top Cited Papers
- 1 November 2007
- journal article
- research article
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 100 (9), 1419-1426
- https://doi.org/10.1016/j.amjcard.2007.06.034
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The pharmacokinetics, pharmacodynamics and tolerability of dabigatran etexilate, a new oral direct thrombin inhibitor, in healthy male subjectsBritish Journal of Clinical Pharmacology, 2007
- A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assaysThrombosis Research, 2005
- Direct Thrombin InhibitorsThe New England Journal of Medicine, 2005
- A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trialJournal of Thrombosis and Haemostasis, 2005
- Warfarin Use among Ambulatory Patients with Nonvalvular Atrial Fibrillation: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) StudyAnnals of Internal Medicine, 1999
- A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction EquationAnnals of Internal Medicine, 1999
- Fibrin d -Dimer and β-Thromboglobulin as Markers of Thrombogenesis and Platelet Activation in Atrial FibrillationCirculation, 1996
- Oral AnticoagulantsSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1995
- Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment.Heart, 1995
- Risk Factors for Stroke and Efficacy of Antithrombotic Therapy in Atrial FibrillationArchives of Internal Medicine, 1994